logo
#

Latest news with #IVD

UPDF keen on launching projects
UPDF keen on launching projects

Time of India

time27-05-2025

  • Business
  • Time of India

UPDF keen on launching projects

Lucknow: A delegation of the UP Diaspora Investors affiliated with the UP-Development Forum (UPDF) also participated in the Invest UP Round Table Conference held in Mumbai on Tuesday. Chairman Pankaj Jaiswal proposed an investor conclave in Lucknow and a roadshow in Dubai in partnership with UPDF to attract the diaspora and encourage investment in the state. He also made several announcements on behalf of his organisation. He said that Kapil Tiwari of the Shree Krishnanand Group has showed interest in the ready mix plaster plant in Lucknow and Noida. Once in place, the project would translate into an investment of Rs 25 crore. Jaiswal added that Rajiv Ranjan Singh of EN Communication was willing to build a Mahabharat Museum in the YIEDA area (near the upcoming international film city) with an investment of Rs 1,500 crore. He also stated that Arnav Gupta of Rimence DSP Infra submitted a proposal to expand its cold emulsion-based road patch mix plant in Lucknow with an investment of Rs 5 crore. In addition to this, Sachidanand Upadhyaya from Lords Group was willing to invest Rs 1,500 crore for setting up a factory for IVD/Medtech and Roof Top Solar. The list also included a proposal by Sachin Singh from Diasys India, who showed interest in expanding its existing plant to double its capacity with an investment of Rs 10 crore.

India Diagnostic Laboratories Market Report 2025-2030: Digital Innovation and Personalized Care Transform the Landscape
India Diagnostic Laboratories Market Report 2025-2030: Digital Innovation and Personalized Care Transform the Landscape

Yahoo

time26-05-2025

  • Business
  • Yahoo

India Diagnostic Laboratories Market Report 2025-2030: Digital Innovation and Personalized Care Transform the Landscape

India's diagnostic laboratory market is on a growth trajectory, fueled by rising healthcare awareness, technological advancements, and chronic disease prevalence. Valued at INR 1.54 Trn in FY 2024, it is expected to reach INR 2.98 Trn by FY 2030, with a CAGR of ~11.70%. Key drivers include government incentives like the PLI scheme, increased foreign investments, and the growing demand for preventative healthcare. The market comprises pathology and radiology segments, with significant contributions from In Vitro Diagnostics (IVD). Additionally, advancements in digital imaging and AI-driven diagnostics are enhancing service accessibility, particularly in rural areas. Dublin, May 26, 2025 (GLOBE NEWSWIRE) -- The "Diagnostic Laboratories Market in India (2025 - 2030)" report has been added to diagnostic laboratories market in India was valued at INR 1.54 Trn in FY 2024. It is expected to reach INR 2.98 Trn by FY 2030, expanding at a compound annual growth rate (CAGR) of ~11.70% during the FY 2025 - FY 2030 period. India's diagnostic laboratory market is poised for substantial growth, driven by rising healthcare awareness, technological advancements, and a growing burden of chronic diseases. The sector is a key component of the healthcare system, facilitating early disease detection and treatment planning. Government initiatives such as the Production Linked Incentive (PLI) scheme and increased foreign investments are expected to further boost this market. The industry is seeing rapid digitization, enhancing accessibility to quality diagnostic services across both urban and rural such as an aging population, increased disposable income, and the shift towards preventive healthcare are fueling growth. The sector comprises both standalone laboratories and hospital-based diagnostic centers, with In Vitro Diagnostics (IVD) playing a crucial role in market expansion. The government's push for local manufacturing, coupled with the PLI 2.0 scheme, aims to enhance domestic production capabilities. India is also a leading hub for medical tourism, contributing to the rising demand for high-quality segmentation:India's diagnostic laboratories market comprises two segments: pathology and radiology Pathology services, including biochemistry, hematology, and microbiology, dominate the market. The IVD sector, covering RT-PCR, ELISA, and molecular diagnostics, is projected to grow significantly due to increasing demand for early disease detection. The radiology segment, covering X-rays, MRI, CT scans, and ultrasound, is witnessing technological advancements. Digital imaging and AI-powered diagnostics are streamlining operations. The Make in India initiative has encouraged domestic manufacturing of high-end imaging equipment, reducing dependency on imports. Tele-radiology services are gaining traction, allowing specialists to analyze scans remotely, particularly in rural trends:The Indian diagnostic laboratories market is undergoing significant transformation, driven by the adoption of digital technologies and a shift towards personalized healthcare. The rise of AI-powered diagnostics, cloud-based platforms, and wearable technology is enhancing test accuracy, speed, and accessibility. Preventive healthcare is gaining traction, with increasing demand for genetic testing, early cancer screening, and wellness packages. Government and private investments, including the PLI scheme and FDI policies, are fostering local manufacturing of diagnostic equipment, reducing reliance on imports and lowering costs. Point-of-care (POC) testing is expanding, providing quick, cost-effective diagnostics in remote areas, while home-based testing is becoming mainstream, supported by mobile sample collection and AI-driven analysis. These trends are collectively shaping a more efficient and patient-centric diagnostic ecosystem in Topics Covered: Chapter 1: Executive SummaryChapter 2: Socio-economic IndicatorsChapter 3: Introduction3.1. Market Definition and StructureChapter 4: Market Overview4.1. India Diagnostic Laboratories Market Overview4.1.1. Market Size and Growth Forecast Based on Value (FY 2022 - FY 2030e)4.2. India Diagnostic Laboratories Market Segmentation -Based on Diagnostic Test Type4.3. Region-wise Labs Accredited by National Accreditation Board for Testing and Calibration Laboratories (NABL)4.4. Regulatory Bodies of Diagnostics Labs Market in India4.5. Distribution of Diagnostics Labs in India (FY 2023)Chapter 5: Market Segmentation5.1. India Diagnostic Laboratories Market Segmentation - Based on Diagnostic Test Type5.2. Pathology Market Size and Growth Forecast (FY2022 - FY2030e)5.3. Radiology Market Size and Growth Forecast (FY 2022 - FY 2030e)Chapter 6: Market Influencers6.1. Market Drivers6.2. Market ChallengesChapter 7: Market Trends7.1. Key Market TrendsChapter 8: Government Initiatives8.1. Favorable Government InitiativesChapter 9: Competitive landscape9.1. Dr. Lal Pathlabs Limited Company information Business description Products/Services Key people Financial snapshot Key ratios Key financial performance indicators Key business segments Key geographic segments Note: Financial information has been covered only for public companies.9.2. Metropolis Healthcare Limited9.3. Suraksha Diagnostic Limited9.4. Thyrocare Technologies Limited9.5. Vijaya Diagnostic Centre Limited9.6. Agilus Diagnostics Limited9.7. Apollo Diagnostics9.8. MEDall Healthcare Private Limited9.9. RedCliffe LabsChapter 10: Recent developments For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

Kia India Constructs Water Tanks and Model Anganwadi Centre in Ammavaripalli Under CSR Drive
Kia India Constructs Water Tanks and Model Anganwadi Centre in Ammavaripalli Under CSR Drive

Hans India

time23-04-2025

  • Automotive
  • Hans India

Kia India Constructs Water Tanks and Model Anganwadi Centre in Ammavaripalli Under CSR Drive

Ammavaripalli: Kia India commenced the groundbreaking ceremony for two overhead water tanks and a 'Model Anganwadi Center' under its 'Integrated Village Development (IVD)' and 'Infra Development for Educational Institutions' projects in Ammavaripalli. These initiatives, part of Kia Social Contributions, aim to enhance drinking water supply and early childhood development in the locality, positively impacting the lives of over 3,200 villagers. To tackle the water scarcity in the community and provide a sustained source of drinking water, the company plans to construct two elevated water tanks, each with a storage capacity of 90,000 Liters to cater the needs of local villagers. The company collaborated with the local Gram Panchayat and the Rural Water Supply Department sustain and support the initiative. Additionally, under its ''Infra Development for Educational Institutions' Project, Kia India will build a 'Model Anganwadi Center' in Ammavaripalli village. This facility will support the holistic development of early childhood and provide essential services to pregnant and lactating women, benefiting around 200 individuals annually. "We are committed to making a positive impact in the communities we serve," said Mr. Kabdong Lee, Chief Administrative Office, Kia India. "These projects reflect our dedication to drive sustainable development and improving the quality of life for the residents of the surrounding villages." Under Kia Social Contributions, the company addresses various needs of the local communities, mainly focusing on Environment, Health, Education and Community Development. The company believes in the concept of 'Give back to the society' to create prosperous environment for the wellbeing of the people and holistic development of the society. About - Kia India In April 2017, Kia India signed a memorandum of understanding (MOU) with the State Government of Andhra Pradesh, India, to build a new manufacturing facility at Anantapur District. Kia commenced mass production in August 2019 and has an installed annual production capacity of 300,000 units. In April 2021, Kia India reimagined itself in line with its new brand identity, 'Movement that Inspires' aimed at offering customers meaningful experiences backed by innovative products and services. Under the new brand identity, Kia has set out to find ways to achieve new benchmarks and inspire consumers to be more and do more. Till date, Kia India has launched seven vehicles for the Indian market – the Seltos, the Syros, the Sonet, the Carens, the Carnival, the EV6 and the EV9. Kia India has completed almost 1.6 million vehicle dispatches from its Anantapur plant, including over 1.2 million domestic sales and over 3.67 lakh exports. With more than 4.5 lakh connected cars on Indian roads, it is among the connected Car leaders in the country. The brand has a widespread network of 700 touchpoints across 300 cities and is focused on strengthening its footprints across the country. For any details, please contact: Shema Ranjay Public Relations, Kia India [email protected] +919962320436

Advanced Lateral Flow Conference Announces 2025 Dates and New Location
Advanced Lateral Flow Conference Announces 2025 Dates and New Location

Yahoo

time27-02-2025

  • Business
  • Yahoo

Advanced Lateral Flow Conference Announces 2025 Dates and New Location

Hilton La Jolla Torrey Pines to Host Premier Lateral Flow Event with Enhanced Programming LA JOLLA, Calif., Feb. 27, 2025 /PRNewswire/ -- The 2025 Advanced Lateral Flow Conference (ALFC), presented by DCN Dx, is set to take place Oct. 14-15, 2025, in a stunning new location: the Hilton La Jolla Torrey Pines in La Jolla, California. Known for its picturesque coastal views and world-class amenities, La Jolla offers attendees an upgraded experience while maintaining the convenience of southern California. The Hilton La Jolla Torrey Pines, located at 10950 North Torrey Pines Road, provides spacious accommodations, state-of-the-art facilities, and a serene environment that fosters both networking and innovation. "We're excited to host this year's ALFC in La Jolla," said Mitzi Rettinger, chair of the ALFC 2025 organizing committee. "The Hilton La Jolla Torrey Pines not only exceeds our needs for space and comfort but also offers attendees an incredible setting to connect and exchange ideas." Attendees will enjoy the same exceptional programming they've come to expect, including opportunities to engage with industry leaders, explore the latest technologies, and gain valuable insights into trends and commercialization strategies. The 2025 conference also promises exciting new features designed to enhance the experience and provide even greater value. DCN Dx is offering special negotiated hotel rates for ALFC attendees. For more information and to book your stay, visit Prefer to call in your reservation? Call the Hilton La Jolla Torrey Pines at (877) 414-8020 and use Group Reservation Code ADVLAT. To learn more and to register, visit About the Advanced Lateral Flow Conference The Advanced Lateral Flow Conference (ALFC), presented by DCN Dx, is the leading global event for lateral flow diagnostic developers, manufacturers, and those driving their commercial success. This annual conference delivers cutting-edge insights through expert-led sessions and provides a platform for researchers and developers to exchange ideas and innovations. Attendees gain practical insights to advance their businesses, deepen their knowledge of rapid diagnostics, and connect with leading minds shaping the future of point-of-care testing. To learn more about ALFC, visit About DCN Dx DCN Dx, based in Carlsbad, California, specializes in lateral flow diagnostics development and manufacturing, and IVD regulatory consulting and clinical research. DCN Dx's multidisciplinary CDMO specializes in creating tailored assay systems, consumables, and instruments for point-of-use applications, with a particular expertise in lateral flow assays. Their clinical research services group specializes in the planning, execution, and oversight of IVD clinical trials, inclusive of clinical operations, data management, and biostatistics, and regulatory services. DCN Dx's personalized approach to IVD product development and clinical trials has supported hundreds of programs and clients. They can oversee every stage from concept to assay development and platform integration, through clinical trials to manufacturing or only handle the aspects you request. In addition to lateral flow assays, DCN Dx's clinical research expertise extends to any in vitro diagnostic, all with a focus on innovation, usability, and performance. With a commitment to quality, customer satisfaction, and industry-leading expertise, DCN Dx is setting the benchmark for excellence in IVD services. To learn more about how we can support your diagnostic needs, visit MEDIA CONTACTMitzi RettingerChief Revenue Officer, DCN DxMain: (760) 804-3886Mobile: (512) 431-5836390793@ View original content to download multimedia: SOURCE DCN Dx Sign in to access your portfolio

Tunisia court orders release of top rights activist
Tunisia court orders release of top rights activist

Yahoo

time19-02-2025

  • Politics
  • Yahoo

Tunisia court orders release of top rights activist

Prominent Tunisian human rights activist Sihem Bensedrine was released from jail on Wednesday after an appeals court ruling, AFP journalists said, although she remains barred from leaving the country. A court spokesman earlier said Bensedrine cannot leave Tunisia as she still faces charges in other cases. "I can only be happy, as no one wants to be in this hole," she said upon her release on Wednesday evening from Manouba prison in the suburbs of the capital. "Breathing the air of freedom like this afternoon and after seeing a just a small patch of blue sky (from her cell), I prayed to God to see the entire sky, and my wish was granted." Bensedrine, 74, headed the now-defunct Truth and Dignity Commission (IVD), which was tasked with uncovering abuses under the country's past autocratic rulers. She had been detained since August for allegedly "falsifying" the commission's final report, which was published in 2020. She has also been accused of accepting a bribe to include a passage accusing the Franco-Tunisian Bank (BFT) of corruption, an allegation she has denied. Her husband, Omar Mestiri, told AFP before her release that Bensedrine "had suffered but is in good spirits". "She is determined to fight to assert her rights," he said. In January, Bensedrine, a former journalist, said she was going on hunger strike in protest at her detention. She was hospitalised 10 days later. Announcing the hunger strike in a letter from Manouba, she had said she would "no longer tolerate the injustice that has struck me. Justice cannot be based on lies and slander, but on concrete and tangible pieces of evidence." - 'Persecution' - Established in 2014 in the aftermath of Tunisia's 2011 revolution, the IVD was tasked with documenting state-led human rights violations between 1955 and 2013. The period includes authoritarian rule in the North African country under presidents Habib Bourguiba and Zine El Abidine Ben Ali, who was ousted during the revolution. The IVD received testimony from tens of thousands of Tunisian victims of abuses including rape and torture. On Tuesday, the United Nations human rights chief denounced the "persecution of political opponents" in Tunisia, urging the authorities to halt a wave of arrests and arbitrary detentions. Bensedrine's lawyer, Abderraouf Ayadi, said in December that the charges were part of a "politically motivated case fabricated against her". "Tunisia's judiciary is currently under political influence," he added, arguing that the charges stemmed from her role as an outspoken critic of the government. President Kais Saied was elected in 2019, after Tunisia emerged as the only democracy from the Arab Spring. But in 2021, he staged a sweeping power grab. Critics and human rights groups have since warned of a rollback on freedoms. Last August, a group of UN experts had called for Bensedrine to be given a fair trial, saying her arrest could amount to judicial harassment. "In a context marked by the suppression of numerous dissenting voices, the arrest of Ms Bensedrine raises serious concerns about the respect of the right to freedom of opinion and expression in Tunisia and has a chilling effect on journalists, human rights defenders and civil society in general," they said in a joint statement. kl-iba/bou/smw/srm

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store